Free Trial

Check-Cap (CHEK) Competitors

Check-Cap logo
$0.78 +0.00 (+0.50%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$0.79 +0.01 (+0.64%)
As of 07/11/2025 07:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CHEK vs. DRCT, SLGL, NXL, IRIX, XAIR, PSTV, IINN, MHUA, INBS, and LYRA

Should you be buying Check-Cap stock or one of its competitors? The main competitors of Check-Cap include Direct Digital (DRCT), Sol-Gel Technologies (SLGL), Nexalin Technology (NXL), IRIDEX (IRIX), Beyond Air (XAIR), Plus Therapeutics (PSTV), Inspira Technologies OXY B.H.N. (IINN), Meihua International Medical Technologies (MHUA), Intelligent Bio Solutions (INBS), and Lyra Therapeutics (LYRA).

Check-Cap vs. Its Competitors

Direct Digital (NASDAQ:DRCT) and Check-Cap (NASDAQ:CHEK) are related small-cap companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

4.0% of Direct Digital shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 62.8% of Direct Digital shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Direct Digital presently has a consensus target price of $6.00, indicating a potential upside of 905.03%. Given Direct Digital's stronger consensus rating and higher possible upside, research analysts clearly believe Direct Digital is more favorable than Check-Cap.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Direct Digital
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Check-Cap
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Direct Digital has higher revenue and earnings than Check-Cap. Direct Digital is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Direct Digital$62.29M0.18-$6.24M-$1.76-0.34
Check-CapN/AN/A-$17.57M-$3.00-0.26

Direct Digital has a beta of 6.07, meaning that its stock price is 507% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500.

In the previous week, Direct Digital and Direct Digital both had 1 articles in the media. Direct Digital's average media sentiment score of 1.87 beat Check-Cap's score of 0.62 indicating that Direct Digital is being referred to more favorably in the media.

Company Overall Sentiment
Direct Digital Very Positive
Check-Cap Positive

Check-Cap has a net margin of 0.00% compared to Direct Digital's net margin of -16.23%.

Company Net Margins Return on Equity Return on Assets
Direct Digital-16.23% N/A -24.12%
Check-Cap N/A N/A N/A

Summary

Direct Digital beats Check-Cap on 10 of the 13 factors compared between the two stocks.

Get Check-Cap News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHEK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHEK vs. The Competition

MetricCheck-CapMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$4.57M$6.82B$5.61B$9.11B
Dividend YieldN/A1.25%5.24%4.02%
P/E Ratio-0.2624.8927.9620.25
Price / SalesN/A65.26430.8999.65
Price / CashN/A20.9237.4658.16
Price / Book0.194.648.045.49
Net Income-$17.57M$174.76M$3.18B$250.27M
7 Day Performance6.95%-1.00%3.67%4.80%
1 Month Performance0.51%-1.49%4.09%7.68%
1 Year Performance-61.52%4.27%29.58%16.36%

Check-Cap Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHEK
Check-Cap
0.6123 of 5 stars
$0.79
+0.5%
N/A-61.5%$4.57MN/A-0.2680
DRCT
Direct Digital
3.5389 of 5 stars
$0.64
+2.7%
$6.00
+837.5%
-84.6%$11.79M$48.17M-0.3660Positive News
SLGL
Sol-Gel Technologies
3.2115 of 5 stars
$7.29
-2.4%
$40.00
+448.7%
-4.7%$20.80M$11.54M-1.5550
NXL
Nexalin Technology
3.0137 of 5 stars
$0.95
-1.1%
$5.00
+426.3%
-28.4%$16.49M$131.07K-1.143
IRIX
IRIDEX
1.0731 of 5 stars
$0.95
+2.2%
N/A-51.4%$15.61M$48.67M-2.21120
XAIR
Beyond Air
4.5149 of 5 stars
$0.19
+6.0%
$1.50
+690.3%
-71.1%$15.46M$3.70M-0.2470News Coverage
Positive News
Gap Down
PSTV
Plus Therapeutics
1.6197 of 5 stars
$0.30
+1.4%
$10.83
+3,505.1%
-80.5%$15.12M$5.82M-0.1020
IINN
Inspira Technologies OXY B.H.N.
2.371 of 5 stars
$1.54
+29.4%
$2.00
+29.9%
-4.0%$15.02MN/A0.0020News Coverage
Analyst Revision
Gap Down
High Trading Volume
MHUA
Meihua International Medical Technologies
1.2339 of 5 stars
$0.41
-5.3%
N/A-49.5%$13.96M$96.91M0.00620Positive News
INBS
Intelligent Bio Solutions
0.8291 of 5 stars
$1.70
-4.5%
N/A-5.9%$12.30M$2.94M0.0010
LYRA
Lyra Therapeutics
2.3908 of 5 stars
$9.03
+0.3%
$100.00
+1,007.4%
-40.8%$11.93M$1.53M-0.1550

Related Companies and Tools


This page (NASDAQ:CHEK) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners